Skip to Content

MML Capital/ Innopharma

M/23/025

Completed

Transaction details

The proposed acquisition by MML Growth Capital Partners Ireland Limited, via Spring Bidco Limited, of sole control of Innopharma Holdings Limited has been cleared by the Competition and Consumer Protection Commission.
Case details
  • Notification date:7 June 2023
  • Publication date:8 June 2023
  • Economic sector:Education - Q
  • Economic sub-sector:Education - Q.85
  • Simplified merger:Yes
  • Outcome:Cleared
Timetable

Phase One

  • Thursday, 8 June, 2023 Notification received
  • Thursday, 22 June, 2023 Third party submission deadline
  • Friday, 23 June, 2023 Determination issued
Parties Involved

MML Growth Capital Partners Ireland Limited

Spring Bidco Limited is a private limited company incorporated in Ireland, established for the purposes of the Proposed Transaction. Spring Bidco Limited is indirectly owned by MML Growth Capital Partners Ireland Fund II LP (“MML Growth Fund II”), a fund managed by MML Growth Capital Partners Ireland Limited (together "MML Capital"). MML Capital is a private equity firm that invests in businesses across various sectors, including healthcare, manufacturing, education services and business services.

 

Innopharma Holdings Limited

Innopharma Holdings Limited ("Innopharma") operates in the State via Innopharma Labs Limited (trading as Innopharma Education) and Innopharma Technology Limited (trading as Innopharma Technical Services).

Innopharma Education is an accredited higher education institute with specialist sector knowledge across its education programmes.

Innopharma Technical Services acts as a contracting business for niche technical roles in high tech manufacturing. Innopharma Technology selects and trains its technical contractors with a view to providing the (bio)pharma industry flexible access to specialist technical skills.

Contacts
Lewis O'Shea lewisoshea@ccpc.ie
View all mergers